Yi Jiang
Fuzhou, 350025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
SNRPD1 inhibition suppresses the proliferation of hepatocellular carcinoma and promotes autophagy through the PI3K/AKT/mTOR/4EBP1 pathway.
Journal: Archives of biochemistry and biophysics
Published: March 30, 2023
Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: December 31, 2022
Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Journal: Journal of hepatocellular carcinoma
Published: November 06, 2022
Primary hepatic mucosa-associated B-cell lymphoma.
Journal: Asian journal of surgery
Published: September 02, 2022
miR-6071 inhibits hepatocellular carcinoma progression via targeting PTPN11.
Journal: Archives of biochemistry and biophysics
Published: March 25, 2022
miR-517b-3p promotes the progression of portal vein tumor thrombus via activating Wnt/β-catenin signaling pathway in hepatocellular carcinoma.
Journal: Molecular biology reports
Published: March 19, 2022
Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular Carcinoma.
Journal: Frontiers in oncology
Published: March 10, 2022
BZW2, CDT1 and IVD Act As Biomarkers for Predicting Hepatocellular Carcinoma.
Journal: Current cancer drug targets
Published: March 07, 2022
A novel ferroptosis-related gene signature for clinically predicting recurrence after hepatectomy of hepatocellular carcinoma patients.
Journal: American journal of cancer research
Published: March 02, 2022
Immune Analysis and Small Molecule Drug Prediction of Hepatocellular Carcinoma Based on Single Sample Gene Set Enrichment Analysis.
Journal: Cell biochemistry and biophysics
Published: October 27, 2021
Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion.
Journal: Bioengineered
Published: October 05, 2021
Last Updated: 09/26/2026